The Leiden University Medical Center (LUMC) has inaugurated a new center aimed at enhancing and expanding treatment options for patients. This initiative reflects LUMC’s commitment to integrating patient care, research, and education to advance healthcare quality and innovation.
The center’s establishment aligns with LUMC’s strategic plan, which emphasizes the integration of core tasks to foster efficiency, cost savings, and ultimately, improved healthcare outcomes. By focusing on personalized, connecting, and curious core values, LUMC aims to create value for patients and society, fostering collaborations between the center and its environment, patients and caregivers, and between theory and practice.
This development underscores LUMC’s dedication to being a pioneer in healthcare innovation, striving to improve patient outcomes through cutting-edge research and tailored treatments.
As of June, the Leiden Bio Science Park team has been joined by Gerwin Zomer, who steps into the role of Account Manager Physical Living Environment. To get to know him a bit...
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from...
VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions VMX‑C001 to meet a gap in urgent haemostasis care.